Overview AVODARTĀ® Alopecia Post-marketing Surveillance (PMS) Status: Completed Trial end date: 2012-12-21 Target enrollment: Participant gender: Summary Post-marketing surveillance(PMS) to monitor the safety and effectiveness of dutasteride in Korean androgenetic alopecia patients Details Lead Sponsor: GlaxoSmithKlineTreatments: Dutasteride